4827 V Pill — YELLOW OVAL, 14mm — Oxycodone

No photo available

Imprint	4827 / V
Colour	YELLOW
Shape	OVAL
Size	14
Strength	OXYCODONE HYDROCHLORIDE 7.5 mg;ACETAMINOPHEN 325 mg
Dosage form	Tablet
Manufacturer	Par Pharmaceutical
NDC	0603-4979
Schedule	CII
Availability	—
Ingredients	OXYCODONE HYDROCHLORIDE[OXYCODONE];ACETAMINOPHEN[ACETAMINOPHEN]

What does this imprint mean?

The imprint "4827 V" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Oxycodone

Uses and warnings

BOXED WARNING - Multiple Serious Risks: - Addiction/Abuse/Misuse: Exposes users to risks that "can lead to overdose and death" - Respiratory Depression: "Serious, life-threatening, or fatal respiratory depression may occur" - Accidental Ingestion: "Even one dose...especially by children, can result in a fatal overdose" - Neonatal Withdrawal: Prolonged pregnancy use risks "neonatal opioid withdrawal syndrome" - CYP3A4 Interactions: Concomitant inhibitors "can result in a fatal overdose" - CNS Depressants/Benzodiazepines: Combined use may cause "profound sedation, respiratory depression, coma, and death" Key Precautions: Monitor for respiratory depression (especially first 24-72 hours), swallow tablets whole (crushing risks fatal dose), assess naloxone need, monitor elderly/debilitated patients closely, avoid in patients with GI obstruction or severe respiratory depression.

Indicated for "management of pain severe enough to require daily, around-the-clock, long-term opioid treatment" in adults and opioid-tolerant pediatric patients ages 11+ already taking at least 20 mg daily oxycodone equivalent. Reserved for patients where "alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate." Not for as-needed use.

Read the full drug profile →